March 2025 GPS Regal Pivotal phase 3 in AML CR2 Study completion Date !
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
SLS Genfleet Positive News R/R DLBCL 02/20/25 🤩
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
Post from Stocktwits 1 million SLS open market Insider buy yesterday 2/12/25 Form 4 coming 🤨
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
Dr. Angelo’s Stergiou Linkedln 2/13/25
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
Sellas Deal PR can hit anytime, Either you in/out or about to be left on the sidelines!
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
Post from Stocktwits Shkreli is short 1.5 million SLS shares at .85, his logic is 80% of cancer drugs fail 🤯🤐🤣
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
1/25/25 Sean Hannity Fiancé with SLS CEO Dr. Angelos Stergiou
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
01/25/25 Fox News Editor Taylor Penley article on Dr. Angelos/sellas/GPS/AI
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
SLS Recent Developments
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
Longs and Novice investors don’t step over hundred 💵Dollar bills to pick up pennies as we are hours away from most binary event in SLS Corporate history GPS Regal phase 3 data in AML CR2 Vs. BAT
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
Excellent post on GPS Valuation upon Positive GPS Regal study in AML CR2 Vs. BAT
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
SLS Change in control, Executive compensation 💵
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
CEO Dr. Angelos Acquired over 600,000 shares on 09/10/25 via Stock options 💵 🚀🚀🚀🚀🚀🚀
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
Excellent post on GPS Regal 60Th event 🧐
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
The Unspoken State of a AML CR2 Patient Facing the End from Oncologist treating actual Patients 😢❤️🩹💎🙌🙏
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
Part of upcoming GPS Regal Interim Analysis Halt for Efficacy.
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
01/12/25 Excellent post from Stocktwits. Sellas has 14 FTE’s(Full Time Employees) per CEO Dr. Angelos Stergiou.
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
One of the best post I have read regarding 01/08/25 update call, especially if you are Long on SLS
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
01/08/2025 SLS to host a call along with world renowned Dr. Levy.
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
News 11/27/2024
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
11/13/2024 CEO Angelo’s statement below seems like GPS Regal trial is coming to conclusion 🧐
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
11/13/2024 SLS ER PR CEO Dr. Angelos made a very powerful forward looking statement. Why is nobody talking about it? 🧐
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice
Interesting 🤨 post on Stocktwits
Gps P3 REGAL Trial Update: All pooled patients, best available therapy and Gps arms combined have an Overall Survival of 16 months. Current best available therapy os known to be 6-8 months, per Dr. Yair Levy the Dir of Hematological Research at Baylor Med. Gps Os 21 months in the Moffitt Center P2 - p value .02 ie 98% reproducibility. FDA Approval only requires 12.6 months of os per the new Sap. - not investment advice